<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="ru">Креативная хирургия и онкология</journal-title><trans-title-group xml:lang="en"><trans-title>Creative surgery and oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2018-8-1-52-56</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-300</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>НИЗКИЙ УРОВЕНЬ АНТИТРОМБИНА III КАК ПРЕДИКТОР РАЗВИТИЯ ТРОМБОТИЧЕСКИХ ОСЛОЖНЕНИЙ У ПАЦИЕНТОВ ХИРУРГИЧЕСКОГО ПРОФИЛЯ</article-title><trans-title-group xml:lang="en"><trans-title>LOW LEVEL OF ANTITHROMBIN III AS A WARNING SIGN FOR DEVELOPING THROMBOTIC COMPLICATIONS IN SURGICAL PATIENTS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Золотухин</surname><given-names>К. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zolotukhin</surname><given-names>K. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., заведующий отделением АРО 1, </p><p>450005, Уфа, ул. Достоевского, 132</p></bio><bio xml:lang="en"><p>Candidate of Medical Sciences, Chief of ICU &amp; Anesthesiology Department,</p><p>132 Dostoevsky str., Ufa, 450005</p></bio><email xlink:type="simple">lkbros5@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0524-7526</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крюгер</surname><given-names>Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Krüger</surname><given-names>Ph.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач анестезиологреаниматолог отделения анестезиологии и интенсивной терапии,</p><p>44137, Дортмунд, Берхауштрассе, 40</p></bio><bio xml:lang="en"><p>MD, Physician of anesthesiology at the Departement of Anesthesiology, Intensive Care and Pain Therapy,</p><p>40 Beurhausstraße, Dortmund, 44137</p></bio><email xlink:type="simple">philipp.krueger@klinikumdo.de</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9302-499X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самородов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Samorodov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., врач анестезиологреаниматолог АРО 1,</p><p>450005, Уфа, ул. Достоевского, 132</p></bio><bio xml:lang="en"><p>Candidate of Medical Sciences, Physician of the Department of ICU &amp; Anesthesiology,</p><p>132 Dostoevsky str., Ufa, 450005</p></bio><email xlink:type="simple">AVSamorodov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Республиканская клиническая больница им. Г.Г. Куватова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>G.G. Kuvatov Republican Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Клиника Дортмунда</institution><country>Германия</country></aff><aff xml:lang="en"><institution>Klinikum Dortmund gGmbH</institution><country>Germany</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>04</day><month>08</month><year>2018</year></pub-date><volume>8</volume><issue>1</issue><fpage>52</fpage><lpage>56</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Золотухин К.Н., Крюгер Ф., Самородов А.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Золотухин К.Н., Крюгер Ф., Самородов А.В.</copyright-holder><copyright-holder xml:lang="en">Zolotukhin K.N., Krüger P., Samorodov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/300">https://www.surgonco.ru/jour/article/view/300</self-uri><abstract><sec><title>Введение</title><p>Введение. Тромбоэмболия легочной артерии (ТЭЛА), являясь самым грозным эмболическим осложнением, характеризуется низкой вероятностью прогноза, высоким процентом летальности, смертности и инвалидизации и, как следствие, высокой экономической стоимостью лечения и реабилитации. В этой связи основной целью нашей работы послужил поиск предикторов развития ТЭЛА у пациентов не кардиохирургического профиля, получавших интенсивную терапию в условиях общехирургического ОРИТ, среди показателей системы гемостаза.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. На базе анестезиолого-реанимационного отделения № 1 хирургического профиля ГБУЗ Республиканская клиническая больница имени Г.Г. Куватова (г. Уфа) был проведен анализ показателей системы гемостаза 430 пациентов, госпитализированных в период с 2010 по 2014 г. Исследование агрегации тромбоцитов осуществляли с помощью лазерного анализатора агрегации тромбоцитов «Биола 230LA». Определение циркулирующих агрегатов проводили по методу Wu — Hoak. Показатели, характеризующие состояние эндотелия, активность коагуляционного звена гемостаза и маркеры процессов тромбообразования и фибринолиза при действии изучаемых веществ, регистрировали на автоматизированном селективном анализаторе гемостаза STA Сompact («Ф. Хоффманн — Ля Рош Лтд», Франция).</p></sec><sec><title>Результаты</title><p>Результаты. Однофакторный анализ выявил наличие связи между госпитальными эпизодами тромбоза и следующими факторами: экстренное хирургическое вмешательство (OR 9,1, p&lt;0,01), заболевание периферических сосудов (OR 13,5, p=0,01), развитие шока в дооперационном периоде (OR 30, p&lt;0,01), высокое содержание D-димеров (OR 30, p&lt;0,01) и низкое содержание АТ III (OR 13,5, p=0,01). По результатам многофакторного анализа значимыми диагностическими критериями являются высокое содержание D-димеров и низкая активность AT III венозной крови.</p></sec><sec><title>Заключение</title><p>Заключение: установленная закономерность позволяет верифицировать высокие риски в отношении вероятности тромбоэмболии легочной артерии и своевременно оценивать эффективность проводимых профилактических мер. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Pulmonary embolism (PE), being the most severe embolic complication, is characterised by low predictability, high mortality and incapacitation rates as well as a correspondingly high economic cost of therapy and aftercare. In this connection, the main purpose of our work is to find a warning for PE development in non-cardiosurgical patients that have undergone intensive therapy under conditions of general surgical ICU, among the indicators of the haemostasis system.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Based at the anaesthesiology and emergency surgical department № 1 of the Kuvatov Republic Clinical Hospital (Russia), the researchers carried out an analysis of the haemostasis system in 430 patients hospitalised between 2010 and 2014. The functional activity of platelets was studied using a Biola 230LA laser platelet aggregation analyser (Russia). The determination of circulating aggregates was conducted using the Wu — Hoak method. Thromboelastography was carried out using a TEG 5000 Thromboelastograph (USA). A Stago STA Compact automated selective haemostasis analyser (France) was used to register indicators that characterise the state of endothelium, the haemostatic coagulation element and thrombosis and fibrinolysis markers.</p></sec><sec><title>Results</title><p>Results. Univariate analysis demonstrated a connection between nosocomial episodes of thrombosis and the following factors: emergency surgery (OR 9.1, p&lt;0.01), peripheral vessel disease (OR 13.5, p=0.01), collapse development in pre-operation period (OR 30, p&lt;0.01), high content of D-dimers (OR 30, p&lt;0.01) and low content of AT III (OR 13.5, p=0.01). The results of multifactor analysis show that the significant diagnostic criteria are high D-dimer content and low AT III venous blood activity.</p></sec><sec><title>Conclusion</title><p>Conclusion. A determination of high risks will enable the incidence of pulmonary embolism to be to minimised as well as provide a timely assessment of the efficiency of preventive measures carried out. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>тромбоэмболия</kwd><kwd>легочная артерия</kwd><kwd>агрегация тромбоцитов</kwd><kwd>фибринолиз</kwd><kwd>хирургический гемостаз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>thromboembolism</kwd><kwd>pulmonary artery</kwd><kwd>platelet aggregation</kwd><kwd>fibrinolysis</kwd><kwd>surgical haemostasis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">European Society of Cardiology. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033–80. DOI: 10.1093/eurheartj/ehu283</mixed-citation><mixed-citation xml:lang="en">European Society of Cardiology. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033–80. DOI: 10.1093/eurheartj/ehu283</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Caprini J.A., Glase S.J., Anderson C.B., Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004;109:I-4–I-8. DOI: 10.1161/01.CIR.0000122869.59485.36</mixed-citation><mixed-citation xml:lang="en">Caprini J.A., Glase S.J., Anderson C.B., Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004;109:I-4–I-8. DOI: 10.1161/01.CIR.0000122869.59485.36</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kodiatte T.A., Manikyam U.K., Rao S.B., Jagadish T.M., Reddy M., Lingaiah H.K.M., et al. Mean platelet volume in type 2 diabetes mellitus. J Lab Physicians. 2012;4(1):5–9. DOI: 10.4103/0974-2727.98662</mixed-citation><mixed-citation xml:lang="en">Kodiatte T.A., Manikyam U.K., Rao S.B., Jagadish T.M., Reddy M., Lingaiah H.K.M., et al. Mean platelet volume in type 2 diabetes mellitus. J Lab Physicians. 2012;4(1):5–9. DOI: 10.4103/0974-2727.98662</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kuderer N.M., Poniewierski M.S., Culakova E., Lyman G.H., Khorana A.A., Pabinger I., et al. Predictors of venous thromboembolism and early mortality in lung cancer: results from a Global Prospective Study (CANTARISK). Oncologist. 2018;23(2):247–55. DOI: 10.1634/theoncologist.2017-0205</mixed-citation><mixed-citation xml:lang="en">Kuderer N.M., Poniewierski M.S., Culakova E., Lyman G.H., Khorana A.A., Pabinger I., et al. Predictors of venous thromboembolism and early mortality in lung cancer: results from a Global Prospective Study (CANTARISK). Oncologist. 2018;23(2):247–55. DOI: 10.1634/theoncologist.2017-0205</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Etzioni D.A., Lessow C., Bordeianou L.G., Kunitake H., Deery S.E., Carchman E., et al. Venous thromboembolism after inpatient surgery in administrative data vs NSQIP: a multi-institutional study. J Am Coll Surg. 2018;S1072–7515(18)30123-6. DOI: 10.1016/j.jamcollsurg.2018.01.053</mixed-citation><mixed-citation xml:lang="en">Etzioni D.A., Lessow C., Bordeianou L.G., Kunitake H., Deery S.E., Carchman E., et al. Venous thromboembolism after inpatient surgery in administrative data vs NSQIP: a multi-institutional study. J Am Coll Surg. 2018;S1072–7515(18)30123-6. DOI: 10.1016/j.jamcollsurg.2018.01.053</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Freund Y., Cachanado M., Aubry A., Orsini C., Raynal P.A., FéralPierssens A.L., et al. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients: The PROPER randomized clinical trial. JAMA. 2018;13;319(6):559–66. DOI: 10.1001/jama.2017.21904</mixed-citation><mixed-citation xml:lang="en">Freund Y., Cachanado M., Aubry A., Orsini C., Raynal P.A., FéralPierssens A.L., et al. Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients: The PROPER randomized clinical trial. JAMA. 2018;13;319(6):559–66. DOI: 10.1001/jama.2017.21904</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pasrija C., Kronfli A., Rouse M., Raithel M., Bittle G.J., Pousatis S., et al. Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: a single-center experience. J Thorac Cardiovasc Surg. 2018;155(3):1095–1106.e2. DOI: 10.1016/j.jtcvs.2017.10.139</mixed-citation><mixed-citation xml:lang="en">Pasrija C., Kronfli A., Rouse M., Raithel M., Bittle G.J., Pousatis S., et al. Outcomes after surgical pulmonary embolectomy for acute submassive and massive pulmonary embolism: a single-center experience. J Thorac Cardiovasc Surg. 2018;155(3):1095–1106.e2. DOI: 10.1016/j.jtcvs.2017.10.139</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kohanna F.H., Smith M.H., Salzman E.W. Do patients with thromboembolic disease have circulating platelet aggregates? Blood. 1984;64(1):205–09. PMID: 6733272</mixed-citation><mixed-citation xml:lang="en">Kohanna F.H., Smith M.H., Salzman E.W. Do patients with thromboembolic disease have circulating platelet aggregates? Blood. 1984;64(1):205–09. PMID: 6733272</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ozdemir B.A., Sinha S., Karthikesalingam A., Poloniecki J.D., Pearse R.M., Grocott M.P., Thompson M.M., Holt P.J. Mortality of emergency general surgical patients and associations with hospital structures and processes. Br J Anaesth. 2016;116(1):54–62. DOI: 10.1093/bja/aev372. PMID: 26675949</mixed-citation><mixed-citation xml:lang="en">Ozdemir B.A., Sinha S., Karthikesalingam A., Poloniecki J.D., Pearse R.M., Grocott M.P., Thompson M.M., Holt P.J. Mortality of emergency general surgical patients and associations with hospital structures and processes. Br J Anaesth. 2016;116(1):54–62. DOI: 10.1093/bja/aev372. PMID: 26675949</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">McCallum I.J., McLean R.C., Dixon S., O’Loughlin P. Retrospective analysis of 30-day mortality for emergency general surgery admissions evaluating the weekend effect. Br J Surg. 2016;103(11):1557–65. DOI: 10.1002/bjs.10261</mixed-citation><mixed-citation xml:lang="en">McCallum I.J., McLean R.C., Dixon S., O’Loughlin P. Retrospective analysis of 30-day mortality for emergency general surgery admissions evaluating the weekend effect. Br J Surg. 2016;103(11):1557–65. DOI: 10.1002/bjs.10261</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fitzgerald J.E.F., Khatri C., Glasbey J.C., Mohan M., Lilford R., Harrison E.M., et al. Mortality of emergency abdominal surgery in high-, middle- and low-income countries. Br J Surg. 2016;103(8):971–88. DOI: 10.1002/bjs.10151</mixed-citation><mixed-citation xml:lang="en">Fitzgerald J.E.F., Khatri C., Glasbey J.C., Mohan M., Lilford R., Harrison E.M., et al. Mortality of emergency abdominal surgery in high-, middle- and low-income countries. Br J Surg. 2016;103(8):971–88. DOI: 10.1002/bjs.10151</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Symons N.R.A., Moorthy K., Almoudaris A.M., Bottle A., Aylin P., Vincent C.A., et al. Mortality in high-risk emergency general surgical admissions. Br J Surg. 2013;100(10):1318–25. DOI: 10.1002/bjs.9208</mixed-citation><mixed-citation xml:lang="en">Symons N.R.A., Moorthy K., Almoudaris A.M., Bottle A., Aylin P., Vincent C.A., et al. Mortality in high-risk emergency general surgical admissions. Br J Surg. 2013;100(10):1318–25. DOI: 10.1002/bjs.9208</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sinha S., Karthikesalingam A., Poloniecki J.D., Thompson M.M., Holt P.J. Inter-relationship of procedural mortality rates in vascular surgery in England retrospective analysis of hospital episode statistics from 2005 to 2010. Circ Cardiovasc Qual Outcomes. 2014;7:131–41. DOI: 10.1161/CIRCOUTCOMES.113.000579</mixed-citation><mixed-citation xml:lang="en">Sinha S., Karthikesalingam A., Poloniecki J.D., Thompson M.M., Holt P.J. Inter-relationship of procedural mortality rates in vascular surgery in England retrospective analysis of hospital episode statistics from 2005 to 2010. Circ Cardiovasc Qual Outcomes. 2014;7:131–41. DOI: 10.1161/CIRCOUTCOMES.113.000579</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ozdemir B.A., Karthikesalingam A., Sinha S., Poloniecki J.D., VidalDiez A., Hinchliffe R.J., et al. Association of hospital structures with mortality from ruptured abdominal aortic aneurysm. Br J Surg. 2015;102(5): 516–24. DOI: 10.1002/bjs.9759</mixed-citation><mixed-citation xml:lang="en">Ozdemir B.A., Karthikesalingam A., Sinha S., Poloniecki J.D., VidalDiez A., Hinchliffe R.J., et al. Association of hospital structures with mortality from ruptured abdominal aortic aneurysm. Br J Surg. 2015;102(5): 516–24. DOI: 10.1002/bjs.9759</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Qiu C., Chan P.H., Zohman G.L., Prentice H.A., Hunt J.J., LaPlace D.C., et al. Impact of anesthesia on hospital mortality and morbidities in geriatric patients following emergency hip fracture surgery. J Orthop Trauma. 2018;32(3):116–23. DOI: 10.1097/BOT.0000000000001035</mixed-citation><mixed-citation xml:lang="en">Qiu C., Chan P.H., Zohman G.L., Prentice H.A., Hunt J.J., LaPlace D.C., et al. Impact of anesthesia on hospital mortality and morbidities in geriatric patients following emergency hip fracture surgery. J Orthop Trauma. 2018;32(3):116–23. DOI: 10.1097/BOT.0000000000001035</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
